|1.||Armstrong, D M: 1 article (01/2001)|
|2.||Ikonomovic, M: 1 article (01/2001)|
|3.||Taylor, M J: 1 article (01/2001)|
|4.||Hentosz, T M: 1 article (01/2001)|
|5.||Shih, S R: 1 article (01/2001)|
|6.||Kelly, K M: 1 article (01/2001)|
|1.||Heart Arrest (Cardiac Arrest)
08/01/1999 - "Effects of hypothermosol, an experimental acellular solution for tissue preservation and cardiopulmonary bypass, on isolated newborn lamb coronary vessels subjected to ultra profound hypothermia and anoxia."
07/01/1994 - "In an attempt to protect cellular integrity during ultraprofound hypothermia (< 10 degrees C) and complete blood substitution, two new crystalloid-colloid blood substitutes (Hypothermosol-maintenance [HTS-M] and Hypothermosol-purge [HTS-P]) have been evaluated. "
07/01/1995 - "Controlled hypotensive, hemorrhagic shock (mean arterial blood pressure < 50 mmHg) was induced for 30 min at normal temperature followed by temporary resuscitation using crystalloid infusion for approximately 10 min. Using our established procedure, the dogs were then cooled externally to 27 degrees C before initiating blood substitution with Hypothermosol (Cryomedical Sciences, Inc. "
|3.||Blood Substitutes (Artificial Blood)
|2.||Cardiopulmonary Bypass (Heart-Lung Bypass)